<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[ivax corp. and tablet Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/ivax+corp.+and+tablet.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to ivax corp. and tablet]]></description>
	<s:counts start="0" returned="9" found="9" />
	<language>en-us</language>
	<item>
		<title><![CDATA[IVAX Receives Final Approval on Clozapine Tablet]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Dec_19/ai_n15952484]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for clozapine tablets USP, 200 mg. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc. Clozapine...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 19 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX to Begin Sale of Morphine Sulfate Controlled-Release Tablets C-II as Authorized Distributor]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_July_29/ai_n14837021]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that its U.S. generic subsidiary, IVAX Pharmaceuticals, Inc., will distribute, in the United States, morphine sulfate controlled-release tablets C-II in 15, 30, 60, 100 and 200 mg dosage strengths supplied by Purdue Pharma LP of Stamford, Connecticut. Morphine sulfate controlled-release tablets...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 29 Jul 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives Final Approval for Doxycycline Hyclate Tablets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_13/ai_n13716669]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) has received final approval from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for doxycycline hyclate 20 mg tablets. This product will be sold through IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc. Doxycycline hyclate 20 mg tablets...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 13 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives Final Approval on 600 and 800 mg Gabapentin Tablets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_May_2/ai_n13664170]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) (WSE:IVX) announced today that it received final approval on April 29, 2005 from the U.S. Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for gabapentin 600 and 800 mg tablets. Upon FDA approval, IVAX' wholly owned subsidiary, IVAX Pharmaceuticals, Inc.,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 02 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX to Begin Marketing Gabapentin Capsules in March, Tablets in April, Prior to End of Alpharma's Exclusivity Periods]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Feb_11/ai_n9511611]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation Announces Settlement of Litigation Against FDA and Alpharma]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 11 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[marketing]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Receives Final Approval of Tizanidine HCL Tablets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_Oct_1/ai_n6216515]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX) (LSE:IVX.L) announced today that it has received final approval from the Federal Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for tizanidine HCl in 2 mg and 4 mg tablet dosages. These tablets will be sold through the company's wholly owned...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 01 Oct 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[IVAX Launches Gabapentin Tablets]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2004_August_18/ai_n6163963]]></link>
		<description><![CDATA[MIAMI -- IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today that it has commenced the initial commercialization of its gabapentin tablets in 100 mg, 300 mg and 400 mg strengths to selected customers. IVAX received final approval of its Abbreviated New Drug Application for these tablets from the FDA in April 2004. As...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 18 Aug 2004 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Ivax Gets Drug OK]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199703/ai_n13234104]]></link>
		<description><![CDATA[IVAX CORPORATION, Miami, Fla., has been granted final marketing  approval for etodolac and acyclovir by US Food & Drug  Administration.     Ivax says it has already begun offering 400 mg tablets of etodolac,  the generic equivalent of ...  IVAX CORPORATION, Miami, Fla., has...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Mar 1997 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/generic.html"><![CDATA[generic]]></category>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
	<item>
		<title><![CDATA[Ivax Ready to Market Generic Terfenadine]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_199701/ai_n13234800]]></link>
		<description><![CDATA[IVAX CORPORATION has received final marketing approval for the  allergy medication terfenadine in 60 mg tablets from Food & Drug  Administration.     The company says it is the first to receive approval for terfenadine,  which is the generic equival  IVAX CORPORATION has received...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 13 Jan 1997 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/ivax+corp..html"><![CDATA[IVAX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/tablet.html"><![CDATA[tablet]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IVX</category>
		<category domain="tickers">IVX</category>
	</item>
</channel>
</rss>
